Companies

ADC Therapeutics SA

ADCT · CIK 0001771910 · operating

$4.18+1.95%Last updated Mar 3, 1:26 AM

Key Statistics

Valuation

Market Cap$517.81M
P/E
Fwd P/E-2.81
PEG
P/S6.88
P/B
EV/EBITDA-6.09
EV/Rev9.85

Profitability

Gross Margin
Op. Margin-184.44%
Net Margin-222.83%
ROE77.89%
ROA-49.02%
FCF Margin-176.04%

Financial Health

Current Ratio3.82
Debt/Equity-2.59
Free Cash Flow-$124.70M
Div. Yield

Growth & Other

Revenue Growth1.84%
EPS Growth44.90%
Beta1.95
52W High$4.8
52W Low$1.05

About ADC Therapeutics SA

ADC Therapeutics SA (ADCT) is a pharmaceutical preparations company incorporated in Switzerland, listed on the NYSE. With a market capitalization of $518 million, ADC Therapeutics SA is a small-cap company. The stock currently trades at $4.18, up 1.95% today, with a 52-week range of $1.05–$4.80.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.62$-1.62+44.9%
2023$-2.94$-2.94

Annual Reports (10-K) · 2 filings

Report DateFiledAccession Number
2024-12-312025-03-270001628280-25-015131SEC ↗
2023-12-312024-03-130001628280-24-010843SEC ↗